Xin Wang

14.9k total citations · 2 hit papers
287 papers, 7.4k citations indexed

About

Xin Wang is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Xin Wang has authored 287 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Molecular Biology, 57 papers in Infectious Diseases and 49 papers in Oncology. Recurrent topics in Xin Wang's work include SARS-CoV-2 and COVID-19 Research (24 papers), Cytokine Signaling Pathways and Interactions (22 papers) and interferon and immune responses (20 papers). Xin Wang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (24 papers), Cytokine Signaling Pathways and Interactions (22 papers) and interferon and immune responses (20 papers). Xin Wang collaborates with scholars based in China, United States and Japan. Xin Wang's co-authors include Jiahui Zheng, Shao Li, Ziyi Wang, Olof Ramström, Mingdi Yan, Siyuan Ding, Ruochen Zang, Jianxin You, Harry B. Greenberg and Kevin Brulois and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Xin Wang

272 papers receiving 7.3k citations

Hit Papers

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human... 2020 2026 2022 2024 2020 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Wang China 45 2.8k 1.5k 1.3k 832 556 287 7.4k
Jian‐Dong Huang Hong Kong 45 3.4k 1.2× 1.3k 0.8× 905 0.7× 584 0.7× 896 1.6× 196 7.6k
Martin Michaelis Germany 53 3.7k 1.3× 1.1k 0.7× 1.0k 0.8× 1.4k 1.7× 446 0.8× 232 9.8k
Sangdun Choi South Korea 49 3.9k 1.4× 469 0.3× 2.0k 1.6× 645 0.8× 391 0.7× 185 8.0k
Xiao Li China 46 3.8k 1.4× 939 0.6× 969 0.8× 1.1k 1.3× 1.1k 1.9× 593 9.4k
Scott L. Diamond United States 57 3.0k 1.1× 906 0.6× 850 0.7× 424 0.5× 1.0k 1.8× 260 11.0k
Xinquan Wang China 39 3.4k 1.2× 5.8k 3.8× 1.8k 1.4× 889 1.1× 440 0.8× 134 10.3k
Wei Zheng United States 57 6.0k 2.1× 1.7k 1.1× 772 0.6× 698 0.8× 944 1.7× 382 12.6k
Ping Huang China 46 4.4k 1.6× 731 0.5× 662 0.5× 1.0k 1.3× 353 0.6× 615 10.3k
Fei Sun China 42 3.8k 1.4× 1.5k 1.0× 450 0.4× 309 0.4× 317 0.6× 219 7.1k
Jacques Fantini France 54 5.2k 1.9× 1.8k 1.2× 1.0k 0.8× 451 0.5× 134 0.2× 242 9.7k

Countries citing papers authored by Xin Wang

Since Specialization
Citations

This map shows the geographic impact of Xin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Wang more than expected).

Fields of papers citing papers by Xin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Wang. The network helps show where Xin Wang may publish in the future.

Co-authorship network of co-authors of Xin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Wang. A scholar is included among the top collaborators of Xin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Wang. Xin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qiyang, Yangyang Li, Ning Yao, et al.. (2025). Astragaloside IV alleviates radiation-induced heart disease by regulating energy metabolism. Phytomedicine. 146. 157135–157135.
3.
Li, Wei, Jianbao Zhang, Xin Wang, et al.. (2025). Enhanced strength-ductility synergy by high density heterogeneous precipitation microstructure in high-entropy alloys. Materials Science and Engineering A. 928. 147983–147983. 13 indexed citations
4.
Jiang, Kaili, Pan Luo, Xin Wang, et al.. (2024). Exploration of the pneumocandin biosynthetic gene cluster based on efficient CRISPR/Cas9 gene editing strategy in Glarea lozoyensis. International Journal of Biological Macromolecules. 279(Pt 2). 135220–135220. 2 indexed citations
5.
Feng, Jiangpeng, Jiejie Liu, Shimin Yang, et al.. (2024). Epitranscriptomic m 5 C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection. Science Advances. 10(32). eadn9519–eadn9519. 11 indexed citations
6.
Wang, Xin, Jie Zhang, Yuanyuan Guo, et al.. (2024). Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents. Signal Transduction and Targeted Therapy. 9(1). 160–160. 2 indexed citations
7.
Li, Weikang, et al.. (2023). Study and application of the shift-temperature of heating fluid for zeotropic mixtures in organic Rankine cycle. International Communications in Heat and Mass Transfer. 145. 106808–106808. 5 indexed citations
8.
Zhang, Meng, et al.. (2021). Synaptic changes and the response of microglia in a light-induced photoreceptor degeneration model. PubMed Central. 27. 206–220. 7 indexed citations
10.
Qi, Furong, Gang Xu, Xuejiao Liao, et al.. (2021). ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers. Cell Discovery. 7(1). 56–56. 6 indexed citations
11.
Li, Zhe, Xin Li, Yi-You Huang, et al.. (2020). Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. Proceedings of the National Academy of Sciences. 117(44). 27381–27387. 177 indexed citations
13.
Zhang, Siqi, Qiaoling Song, Xueting Wang, et al.. (2019). Virtual Screening Guided Design, Synthesis and Bioactivity Study of Benzisoselenazolones (BISAs) on Inhibition of c-Met and Its Downstream Signalling Pathways. International Journal of Molecular Sciences. 20(10). 2489–2489. 8 indexed citations
15.
Huang, Yalan, Dana Huang, Yijie Geng, et al.. (2017). An Integrated Control Strategy Takes Clonorchis sinensis Under Control in an Endemic Area in South China. Vector-Borne and Zoonotic Diseases. 17(12). 791–798. 11 indexed citations
16.
Wang, Yuxin, Nan Jing, Belinda Willard, et al.. (2016). Negative regulation of type I IFN signaling by phosphorylation of STAT 2 on T387. The EMBO Journal. 36(2). 202–212. 26 indexed citations
17.
Shen, Aijun, Lu Wang, Min Huang, et al.. (2015). c-Myc Alterations Confer Therapeutic Response and Acquired Resistance to c-Met Inhibitors in MET-Addicted Cancers. Cancer Research. 75(21). 4548–4559. 37 indexed citations
18.
Shi, Zhubing, Zhen Zhang, Zhenzhen Zhang, et al.. (2015). Structural Insights into Mitochondrial Antiviral Signaling Protein (MAVS)-Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Signaling. Journal of Biological Chemistry. 290(44). 26811–26820. 38 indexed citations
19.
Wang, Dejuan, Dong Uk Yang, Li‐Da Su, et al.. (2012). Cytosolic Phospholipase A2 alpha/Arachidonic Acid Signaling Mediates Depolarization-Induced Suppression of Excitation in the Cerebellum. PLoS ONE. 7(8). e41499–e41499. 11 indexed citations
20.
Dong, Chenfang, Song Shi, Xiao‐Fan Wang, et al.. (2007). The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. Archives of Biochemistry and Biophysics. 470(1). 83–92. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026